Table 4 Impact of price deregulation on patients’ medical expenditure for non-dominant diseases
From: Deregulation and pricing of medical services: a policy experiment based in China
Total expenditure | Diagnostic test expenditure | Drug expenditure | Service expenditure | Proportion of diagnostic test expenditure | Proportion of drug expenditure | |
|---|---|---|---|---|---|---|
Privite | 0.068*** | 0.042*** | 0.231*** | − 0.102*** | −0.029*** | 0.069*** |
(0.007) | (0.012) | (0.011) | (0.008) | (0.002) | (0.002) | |
Time | −0.092*** | − 0.068*** | − 0.459*** | 0.032*** | 0.049*** | − 0.095*** |
(0.007) | (0.014) | (0.011) | (0.008) | (0.002) | (0.001) | |
Privite#time | 0.100*** | −0.957*** | − 0.191*** | 0.284*** | − 0.046*** | − 0.019*** |
(0.009) | (0.029) | (0.016) | (0.012) | (0.002) | (0.002) | |
Constant | 7.053*** | 4.709*** | 5.875*** | 6.362*** | 0.160*** | 0.353*** |
(0.025) | (0.066) | (0.036) | (0.028) | (0.006) | (0.006) | |
ICD code | Yes | Yes | Yes | Yes | Yes | Yes |
Time fixed effect | Yes | Yes | Yes | Yes | Yes | Yes |
Control variables | Yes | Yes | Yes | Yes | Yes | Yes |
N | 170,510 | 169,909 | 170,220 | 169,904 | 169,087 | 169,398 |
R-squared, | 0.382 | 0.148 | 0.373 | 0.404 | 0.227 | 0.350 |